• Product NameVinorelbine
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityVinorelbine (Navelbine?) is an anti-mitotic chemotherapy drug that is given as a treatment for some types of Y, including breast Y and non-small cell lung Y.
• Target NameMicrotubule Associated inhibitor
• CAS No. 71486-22-1
• Calculated MW 778.93
• Formulation C45H54N4O8
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cancer
  SMILES:CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
  Pathways:Cytoskeletal Signaling
  Receptor:Tubulin β chain
  Boling pt:
  Melting pt:
  Solubility:DMSO 100 mg/mL;Water 100 mg/mL
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Fellous A, et al. Semin Oncol. 1989, 16(2 Suppl 4), 9-14.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting